EyePoint Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: EyePoint Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: EyePoint Pharmaceuticals Inc
Rating: 1.12175
Author: Trendlyne DVM scores

about

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's...

13.24 -0.19 (-1.41%)

30.72% Fall from 52W High

514.8K

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

8.5 / 100

Technically Neutral

36.4 / 100

1Yr Price target upside is 181%

12 analysts

EyePoint Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

EyePoint Pharma Inc Live Stock Price Today, Share Analysis and Chart

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's...

30.72% Fall from 52W High

SWOT Analysis

EyePoint Pharma Inc Live Price Chart